Doc's note: Investing in the resource sector is a quick way to lose money for most investors. But smart investors can make life-changing gains. As legendary resource investor Rick Rule explains today, if you don't want to be a victim, you need to be a contrarian...

If you're going to invest in natural resources, you have two choices...

Be a contrarian or be a victim. There's no middle ground.

That may sound blunt, but it's a truth I've found after five decades of investing through every kind of commodities cycle.

Resources are volatile, capital-intensive, and politically charged. They attract hype when prices rise and contempt when they fall. And yet, over the long term, they are essential to human progress.

That disconnect between perception and necessity is where the real money is made – if you're willing to invest when others are fleeing.

Most investors get this wrong. They pile in when prices are high and hype is buzzing. But in commodities, by the time investors are excited, much of the opportunity is already gone.

Let me say this clearly: The best time to buy a commodity isn't when it's loved – it's when it's hated.

You want to buy when the price is below the industry's average cost of production... when companies are shutting down operations... when headlines scream that demand is dead, that a material is obsolete, or worse – "toxic."

That's when I lean in...

I've seen it too many times to count.

In the early 2000s, uranium was selling for $10 a pound. It cost $40 to produce. The industry was in liquidation. People thought nuclear was dead.

But what were the choices? Coal? That wasn't politically palatable.

Wind and solar? They were intermittent and expensive at the time.

The math was simple: Either uranium prices went up, or the lights went out. Sure enough, the price soared to $140.

We saw a version of this again not long ago...

In 2020, and for years prior, uranium was trading around $20 a pound. It cost roughly $60 per pound to restart old mines. And yet utilities needed it more than ever as the world rediscovered that baseload, non-carbon energy isn't optional.

When I saw that opportunity, I said: Whenever the price of a commodity is below the cost to produce it, it's not a question of "if" it will rise, but "when."

Uranium went on a tear... Today, it sits above $86 per pound.

This isn't a uranium story, though. It's an investing principle. The phrase I use to describe it is, "Inevitable, even if not imminent."

And if you understand the difference between those two words – inevitable and imminent – you'll understand how I approach every investment I make...

The Contrarian Formula in Commodities Investing

You don't need to get the timing perfect.

You do need to get the trend directionally correct – and be early. That's where the money is.

In fact, being early is the only way to capture the outsized gains that resource investing can deliver. I've had speculations where the worst-performing stock went up 22-fold.

But I was six years early. If you can't tolerate that lag, you're in the wrong business.

To succeed, you must have the stomach to invest when it feels most uncomfortable – when there's blood in the streets... even your own. You need to buy when companies are cutting capital expenditures, not increasing them. When management is despised, not fawned over. When the newsletter writers have all moved on to crypto.

The irony is that risk is lowest when perception of risk is highest. That's the contrarian's edge.

If a commodity is essential and current prices make production uneconomic, then supply will shrink until prices adjust. That's how markets work.

And in extractive industries, supply can't respond overnight. It takes years to permit, finance, and build a new mine or oil well. That lag creates the window for real upside.

Let me give you a mental framework. When you're evaluating a commodity, ask:

  1. Is this material essential to the functioning of modern life?
  1. Is it currently priced below the cost of production?
  1. Is the industry in liquidation or distress?
  1. Is demand likely to recover, or alternatively, is the commodity a long-term necessity?

If you can answer "yes" to all four, you're likely looking at a good contrarian opportunity.

If you can also find a company with a strong balance sheet, tier-one assets, and disciplined management that knows the difference between growth and value – then you might just have a 10-bagger on your hands.

But don't expect it to come quickly...

Commodities move in long, violent cycles. Bull markets can last a decade, but they're born in despair and die in euphoria. And most investors are wired to buy euphoria and sell despair. That's why I say: You're either a contrarian or a victim.

Now, some will say, "Rick, that's easier said than done." And they're right. It's psychologically hard. That's why it works.

Markets don't reward the crowd. They reward the disciplined, the prepared, and yes – the uncomfortable.

It helps to remember one last thing...

The cure for low prices is low prices. It always has been, and it always will be.

Industries can't run at a loss forever. Capital walks. Supply shrinks. And eventually, price responds. If you position yourself before that happens, and if you can wait it out, the rewards can be extraordinary...

But only if you're willing to buy when everyone else thinks you've lost your mind.

Regards,

Rick Rule

Editor's note: Rick says that Washington is in the midst of a desperate effort to spend $12 billion buying and stockpiling key natural resources that are largely controlled by Beijing.

In the next 100 days or so, it's set to create a major tailwind for a handful of resource stocks – which could hand you a rare chance to make 5, 10, or even 50 times your money.

And today, he's showing folks exactly where to put their money. Click here for all the details.

Recent Articles

View Full Archives
Subscribe to Health & Wealth Bulletin for FREE
Get the Health & Wealth Bulletin delivered straight to your inbox.
About Health & Wealth Bulletin

Here at Health & Wealth Bulletin, our manifesto is to provide a guide for living well – at a good price and on your own terms.

We've told folks the secret to life-changing income in retirement, the exit plan that every investor needs, and the key to beating the market. And our team has been on the leading edge of reporting new discoveries like immunotherapy, the dangers of BPA, the truth about cholesterol, and more.

You see, huge corporate interests and corrupt government institutions would rather people didn't know about many of these concepts... The more ignorant the people are, the better for the government and corporate interests. This keeps folks dependent... and the "nanny state" alive. That's why we spend our days uncovering the truth and sharing it with readers.

Health & Wealth Bulletin is your free guidebook to intriguing health and wealth ideas. It's all about living the best life possible.

About the Editor
Dr. David "Doc" Eifrig
Dr. David "Doc" Eifrig
Editor

Dr. David "Doc" Eifrig has one of the most remarkable resumes of anyone we know in the finance industry. After receiving his Bachelor of Arts degree from Carleton College in Minnesota, he went on to earn a Master of Business Administration degree

from Northwestern University's Kellogg School of Management. There, he graduated on the Dean's List with a double major in finance and international business.

Doc then went to work as an elite derivatives trader at the Goldman Sachs investment bank. He spent a decade on Wall Street with several major institutions, including Chase Manhattan Bank and Yamaichi Securities (then known as the "Goldman Sachs of Japan").

That's when Doc's career took an unconventional turn. Sick of the greed and hypocrisy on Wall Street, he quit his Senior Vice President position to become a doctor. He graduated from Columbia University's postbaccalaureate premedical program and eventually earned his Medical Doctor degree with clinical honors from the University of North Carolina at Chapel Hill. While in medical school, he was elected president of his class and admitted to the Order of the Golden Fleece – the highest honor awarded at the university.

Doc also completed a research fellowship in molecular genetics at Duke University and became a board-eligible eye surgeon. Along the way, he has been published in scientific journals and helped start a small biotechnology company, Mirus Bio, which was sold to Roche for $125 million in 2008.

However, frustrated by Big Medicine's many conflicts, Doc began to look for ways to talk directly with individuals. He wanted to use his background to show them how to take control of their health and wealth. In 2008, Doc joined Stansberry Research and launched his publication, Retirement Millionaire. He has gone on to launch Retirement Trader, which uses options to help people construct safe, reliable income streams. Doc's Income Intelligence seeks out income-producing investments to maximize returns. Prosperity Investor helps investors unlock massive potential gains in health care investing. Every Monday through Friday, Doc shares his views on the latest in the financial and health industries – and tips on how to improve your own life – in Health & Wealth Bulletin.

Doc has also authored five books with four-star ratings (or better) on Amazon. In his spare time, he has run three marathons and several triathlons. He owns and produces his own wine (Eifrig Cellars) in northern Sonoma County, California. Doc is also the CEO of MarketWise, Stansberry Research's parent company.

Back to Top